Literature DB >> 15834169

Possible reasons for lack of effect of allergen avoidance in atopy-prone infants and sensitive asthmatic patients.

I Romei1, Attilio L Boner.   

Abstract

The basic paradigm that allergen exposure produces atopic sensitization, and that continued exposure leads to clinical asthma throughout the development of airway inflammation and bronchial hyperreactivity has been challenged. However, because it was observed that epidemiological evidence suggests that around 40% of asthma cases are attributable to atopy (even using restrictive criteria), the obvious corollary is that if allergen avoidance begins before the onset of sensitization (primary prevention), then it should be associated with a reduced number of new cases of the disease. However, there are conflicting results regarding the effect of allergen avoidance on primary prevention of atopic sensitization and asthma onset. Instead, more uniform and positive results are available from secondary prevention studies. Secondary prevention obviously is an attractive opportunity for pediatricians who may recognize the patients who might benefit from these interventions simply by screening for food allergy in young children with atopic dermatitis. The conflicting results of tertiary prevention are most frequently observed in adult patients and sometimes result from incomplete avoidance of allergens responsible for the sensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834169     DOI: 10.1385/CRIAI:28:1:059

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  127 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Can we predict atopic disease using perinatal risk factors?

Authors:  R L Bergmann; K E Bergmann; U Wahn
Journal:  Clin Exp Allergy       Date:  1998-08       Impact factor: 5.018

3.  House dust mite allergen avoidance in asthma. Benefits unproved but not yet excluded.

Authors:  D P Strachan
Journal:  BMJ       Date:  1998-10-24

4.  Allergen avoidance in a day-care center.

Authors:  A K Munir; R Einarsson; S Dreborg
Journal:  Allergy       Date:  1996-01       Impact factor: 13.146

5.  Preventive effect of bedding encasement with microfine fibers on mite sensitization.

Authors:  K Nishioka; H Yasueda; H Saito
Journal:  J Allergy Clin Immunol       Date:  1998-01       Impact factor: 10.793

Review 6.  Can house dust mite-triggered atopic dermatitis be alleviated using acaricides?

Authors:  M M Cameron
Journal:  Br J Dermatol       Date:  1997-07       Impact factor: 9.302

Review 7.  Cockroach allergens and asthma.

Authors:  L K Arruda; L D Vailes; V P Ferriani; A B Santos; A Pomés; M D Chapman
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

8.  The use of domestic steam cleaning for the control of house dust mites.

Authors:  M J Colloff; C Taylor; T G Merrett
Journal:  Clin Exp Allergy       Date:  1995-11       Impact factor: 5.018

9.  Transient sensitization to house-dust mites: a study on the influence of mite exposure and sex.

Authors:  M Wickman; J Korsgaard
Journal:  Allergy       Date:  1996-07       Impact factor: 13.146

10.  Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling.

Authors:  H Tanaka; T Masuda; S Tokuoka; Y Takahashi; M Komai; K Nagao; H Nagai
Journal:  Inflamm Res       Date:  2002-06       Impact factor: 4.575

View more
  1 in total

1.  Periostin promotes chronic allergic inflammation in response to Th2 cytokines.

Authors:  Miho Masuoka; Hiroshi Shiraishi; Shoichiro Ohta; Shoichi Suzuki; Kazuhiko Arima; Shigehisa Aoki; Shuji Toda; Naoki Inagaki; Yuichi Kurihara; Sayaka Hayashida; Satoshi Takeuchi; Kenta Koike; Junya Ono; Hirokazu Noshiro; Masutaka Furue; Simon J Conway; Yutaka Narisawa; Kenji Izuhara
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.